|
David McLeod Herrington, M.D., M.H.S.
 Professor of Internal Medicine-Cardiology
Associate in Public Health Sciences (Epidemiology)
Wake Forest Unviersity School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157-1045
336-716-4950
dherring@wfubmc.edu
EDUCATION:
-
B.S., Mathematics, Davidson College
-
M.D., University of North Carolina School of Medicine, Chapel Hill, NC
-
M.H.S., Epidemiology, The Johns Hopkins University School of Hygiene and Public Health
|
CURRENT RESEARCH INTERESTS :
-
Pathogenesis and prevention of atherosclerosis cardiovascular genetic risk factors pharmacogenetics of estrogen action non-invasive measurement of endothelial function women and heart disease machine learning applications in genome-wide association studies
|
RECENT PUBLICATIONS:
-
Lakoski SG and Herrington DM. Gender and C-Reactive Protein: Data from the Multi-Ethnic study of Atherosclerosis (MESA) Cohort. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism 2005
-
Mellen PB, and Herrington DM, Insulin resistance and atherosclerotic progression: the Estrogen Replacement and Atherosclerosis study. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism 2005
-
Mellen PB and Herrington DM. Diabetes, but not the metabolic syndrome, predicts coronary atherosclerotic progression in postmenopausal women: the Estrogen Replacement and Atherosclerosis study. 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism 2005
-
Ouyang P, Tardif Jean-Claude, Herrington DM, Stewart Kerry J., Thompson PD, Walsh MN, Bennett SK, Heldman AW, Wang NY.Differential effect of hormone therapy on angiographic disease progression in saphenous vein grafts and native coronary arteries. Circulation 2005; 112 (Suppl II):II-666.
-
Wenger NK, Welty F, Lewis S, Herrington DM, Bittner V, Bittner V, Welty FK. Effect of 80mg versus 10 mg of Atorvastatin in patients ≥ and <65 years of age with stable coronary heart disease. Circulation 2005; 112 (Suppl II):II-662.
-
Wenger NK, Welty F, Lewis S, Herrington DM, Bittner V. Effect of 80mg versus 10 mg of Atorvastatin in women and men with stable coronary heart disease. Circulation 2005; 112 (Suppl II):II-819.
-
Hsia J, Herrington DM, Criqui MH, Wu L, Robinson J, Manson J, Allison M, Heckbert SR, Masaki K, McDermott M. Unopposed conjugated equine estrogens and the risk of peripheral arterial disease. Circulation 2005; 112 (Suppl II):II-358.
-
He K, Daviglus ML, Jenny N, Mayer-Davis E, Steffen L, Siscovick D, Herrington DM. Associations of dietary long-chair N-3 faty acids and fish with biomarkers of inflammation and endothelial activation: The Multi-Ethnic Study of Atherosclerosis (MESA) Circulation 2005; 112 (Suppl II):II-107.
-
Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Zu J, Bowden DW, Herrington DM. Variation in innate immunity gene (IRAK1) is associated with c-reactive protein in Caucasian women in the Diabetes Heart Study (DHS). Circulation 2005; 112 (Suppl II):II-785.
-
Jenny NS, Brown ER, Detrano R, Folsom AR, Saad MF, Shea S, Szklo M, Herrington DM, Jacobs DR Jr. Association of fibrinogen with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005; 112 (Suppl II):II-799.
-
Mellen PB, Herrington DM. How low should go you?: High-normal two-hour glucose predicts coronary disease progression in postmenopausal women. Circulation 2005; 112 (Suppl II):II-820.
-
Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein and incident hypertension in young adults: the CARDIA Study. Circulation 2005; 112 (Suppl II):II-822.
-
Erkkila AT, Matthan NR, Jalbert SM, Restgehini NA, Herrrington DM, Lichtenstein AH. Long-chain N-3 fatty acids in serium phospholipids are associated with reduced progression of coronary-artery atherosclerosis in women with documented coronary artery disease. Circulation 2005; 112 (Suppl II):II-834.
|
|
|
|
